The Effect of Managed Care on the Pharmaceutical Industry

DSpace/Manakin Repository

The Effect of Managed Care on the Pharmaceutical Industry

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Carson, Cheryl J. en_US
dc.date.accessioned 2012-07-06T21:28:33Z
dc.date.issued 1997 en_US
dc.identifier.citation The Effect of Managed Care on the Pharmaceutical Industry (1997 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965565
dc.description.abstract The pharmaceutical industry has transformed itself in response to the growth of managed care, which developed as a method to contain the costs of health care. Under the traditional fee-for-service system of practicing medicine, doctors practiced medicine without incentives to reduce the costs imposed on patients, their insurers, and the health care system. Most doctors practiced independently and were reimbursed for each service rendered by passive insurance companies. Shielded from the oversight of third-party intermediaries, doctors had financial incentives to provide more services, regardless of whether those services were therapeutically necessary. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject managed care en
dc.subject human drugs en
dc.subject pharmaceutical industry en
dc.title The Effect of Managed Care on the Pharmaceutical Industry en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-07-06T21:28:33Z

Files in this item

Files Size Format View
ccarson.pdf 309.9Kb PDF View/Open
ccarson.rtf 160.8Kb RTF file View/Open
ccarson.html 107.6Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters